Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar

Cancer Research

Volumn 64, Issue 19, 2004, Pages 7058-7064

  Li, Yingyi ^a   Aoki, Takanori ^a,b   Mori, Yuya ^a   Ahmad, Munirah ^a   Miyamori, Hisashi ^a   Takino, Takahisa ^a   Sato, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Daiichi Fine Chemical Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BATIMASTAT; COMPLEMENTARY DNA; CORE PROTEIN; GENE PRODUCT; GLUTATHIONE TRANSFERASE; LEUCINE; LUMICAN; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN P21; PROTEOGLYCAN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CATTLE; COLONY FORMATION; CONTROLLED STUDY; CORNEA; CULTURE MEDIUM; DNA LIBRARY; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

CELL DIVISION; CELL LINE; COLLAGENASES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EMBRYO; ENZYME PRECURSORS; GELATINASES; GENE LIBRARY; HELA CELLS; HUMANS; KERATAN SULFATE; KIDNEY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PROTEOCHONDROITIN SULFATES; TRANSFECTION; TUMOR STEM CELLS;

EID: 4944233738     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1038     Document Type: Article

References (50)

1. Danielson KG, Siracusa LD, Donovan PJ, Iozzo RV. Decorin. epiphycan, and lumican genes are closely linked on murine Chromosome 10 and are deleted in lethal steel mutants. Mamm Genome 1999;10:201-3.
2. Hocking AM, Shinomura T, McQuillan DJ, Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998;17:1-19.
3. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 1999;274:18843-6.
4. Iozzo RV, Murdoch AD. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996;10:598-614.
5. Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001;12: 69-78.
6. Ying S, Shiraishi A, Kao CW, et al. Characterization and expression of the mouse lumican gene. J Biol Chem 1997;272:30306-13.
7. Iozzo RV, Chakrani F, Perrotti D, et al. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci USA 1999;96:3092-7.
8. Chakravarti S, Petroll WM, Hassell JR, et al. Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. Investig Ophthalmol Vis Sci 2000;41:3365-73.
9. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991;64:867-9.
10. Stander M, Naumann U, Wick W, Weller M. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 1999;296:221-7.
11. Kolettas E, Rosenberger RF. Suppression of decorin expression and partial induction of anchorage-independent growth by the v-src oncogene in human fibroblasts. Eur J Biochem 1998;254:266-74.
12. Yoshioka N, Inoue H, Nakanishi K, et al. Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras. J Virol 2000;74:1008-13.
13. Seiki M. Membrane-type matrix metalloproteinases, APMIS 1999;107:137-43.
14. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274: 21491-4.
15. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995;55:3263-66.
16. Ueno H, Nakamura H, Inoue M, et al. Expression and Tissue localization of membrane-type 1, 2 and 3 matrix metalloproteinases in human invasive breast carcinoma. Cancer Res 1997;57:2055-60.
17. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999;9:1441-7.
18. Gearing AJ, Beckett P, Chrisvodoulou M, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (Lond) 1994;370:555-7.
19. Levi E, Fridman R, Miao HQ, et al. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA 1996; 93:7069-74.
20. Suzuki M, Raab G, Moses MA, Fernandez CA, Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 1997;272:31730-7.
21. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-81.
22. Ito A, Mukaiyama A, Itoh Y, et al. Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 1996;271:14657-60.
23. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H, Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994;269:25742-6.
24. Killer O, Lichte A, Oberpichler A, Kocourek A, Tschesche H, Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem 2000;275:33008-13.
25. McQuibban GA, Gong JH, Tam EM, et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science (Wash DC) 2000;289: 1202-6.
26. McQuibban GA, Butler GS, Gong JH, et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001;276: 43503-8.
27. McQuibban GA, Gong JH, Wong JP, et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002;100:1160-7.
28. Takino T, Koshikawa N, Miyamori H, et al. Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. Oncogene 2003;22: 4617-26.
29. Endo K, Takino T, Miyamori H, et al. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 2003;278:40764-70.
30. Miyamori H, Takino T, Kobayashi Y, et al. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem 2001;276:28204-11.
31. Nakada M, Yamada A, Takino T, et al. Suppression of membrane-type I matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its spiking variant gene product, N-Tes. Cancer Res 2001;61:8896-902.
32. Kinoshita T, Sato H, Okada A, et al. TIMP-2 promotes activation of progelatinase A by membrane-type I matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998;273:16098-103.
33. Shimada T, Nakamura H, Ohuchi E, et al. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Eur J Biochem 1999;262: 907-14.
34. De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 1996;271:18961-5.
35. Schonherr E, Levkau B, Schaefer L, Kresse H, Walsh K, Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem 2001;276:40687-92.
36. Santra M, Mann DM, Mercer EW, et al. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21. an inhibitor of cyclin-dependent kinases. J Clin Investig 1997;100:149-57.
37. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond) 1994;370:61-5.
38. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type I-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996;393:101-4.
39. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane-type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51.
40. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Vito Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000;148:615-24.
41. Ratnikov BI, Rozanov EV, Postnova TI, et al. An alternative processing of integrin αv subunit in tumor cells by membrane type-I matrix metalloproteinase. J Biol Chem 2002;277:7377-85.
42. Belkin AM, Akimov SS, Zaritskayai LS, et al. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 2001;276:18415-22.
43. Higashi S, Miyazaki M. Identification of a region of β-amyloid precursor protein essential for its gelatinase a inhibitory activity. J Biol Chem 2003;278:14020-8.
44. Tam EM, Morrison CJ, Wu YI, Stack MS, Overall CM. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc Natl Acad Sci USA 2004;101:6917-22.
45. Moscatello DK, Santra M, Mann DM, et al. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Investig 1998;101:406-12.
46. Patel S, Santra M, McQuillan DJ, Iozzo RV, Thomas AP. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells. J Biol Chem 1998;273:3121-4.
47. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999;274:4489-92.
48. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. Degradation of decortn by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 1997;322: 809-14.
49. Leygue E, Snell L, Dotzlaw H, et al. Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 2000;192:313-20.
50. Reed CC, Gauldie J, Iozzo RV. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene 2002;21:3688-95.